Tenofovir Disoproxil Fumarate Tablets IP 300 MG – First-Line Choice for Long-Term Viral Suppression.
ZEFOTEN 300 Tablets: The Composition of Tenofovir Fumarate 300 mg is a nucleotide reverse transcriptase inhibitor (NtRTI) widely prescribed in the management of HIV-1 infection and chronic Hepatitis B virus (HBV) infection. It works by blocking viral replication, thereby lowering viral load, slowing disease progression, and supporting immune system recovery. As a proven first-line therapy, Tenofovir Disoproxil Fumarate offers reliable antiviral efficacy and long-term clinical benefits in both HIV and HBV patients.
Recommended By Specialists:
✅Hepatologists and gastroenterologists: It is preferable to treat the disease associated with chronic HBV infection to effectively control it and prevent liver complications.
✅HIV Specialists: It is preferable to treat the disease associated with the backbone agent in antiretroviral therapy (ART) regimens.
✅General Physicians: It is preferred to treat the disease associated with long-term management of HIV and HBV in routine care.
Key benefits of Tenofovir Disoproxil Fumarate Tablets IP 300 MG – ZEFOTEN 300 Tablets:
✅Dual Antiviral Power – Effective against both HIV-1 and chronic HBV infections.
✅Well-Established Efficacy – Clinically proven to reduce viral replication and delay disease progression.
✅First-Line Therapy – Recommended worldwide in ART and HBV treatment guidelines.
✅Convenient Once-Daily Dose: Improves patient adherence and treatment outcomes.
Indications:
✅HIV-1 Infection (in combination with other antiretrovirals)
✅Chronic Hepatitis B Virus (HBV) Infection
✅Long-term Antiviral Therapy for Immunocompromised Patients
✅Core Component of ART for Adults and Adolescents











